Amgen Inc.
AMGN
$296.47
$6.182.13%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.08% | 10.61% | 11.27% | 24.48% | 20.32% |
| Total Other Revenue | 17.58% | -16.11% | 1.93% | -0.85% | 14.52% |
| Total Revenue | 9.43% | 9.43% | 10.86% | 23.18% | 20.07% |
| Cost of Revenue | 3.73% | 3.91% | -71.01% | 83.28% | 42.08% |
| Gross Profit | 11.96% | 12.23% | 45.89% | 1.88% | 12.35% |
| SG&A Expenses | -5.27% | -6.69% | 5.09% | 20.10% | 37.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 600.00% | -18.92% | 108.35% | -91.91% | -89.52% |
| Total Operating Expenses | 6.27% | 1.98% | -12.40% | 28.24% | 34.54% |
| Operating Income | 16.58% | 33.62% | 47.23% | 9.61% | -3.46% |
| Income Before Tax | 97.48% | 3,001.47% | -8.22% | 59.27% | -50.81% |
| Income Tax Expenses | 183.33% | 440.00% | 82.35% | 24.88% | -79.57% |
| Earnings from Continuing Operations | 91.96% | 1,630.97% | -18.25% | 63.58% | -45.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 91.96% | 1,630.97% | -18.25% | 63.58% | -45.90% |
| EBIT | 16.58% | 33.62% | 47.23% | 9.61% | -3.46% |
| EBITDA | 9.25% | 18.31% | 35.04% | 24.59% | 11.58% |
| EPS Basic | 91.60% | 1,625.43% | -18.55% | 62.98% | -46.10% |
| Normalized Basic EPS | 11.77% | 46.66% | 74.76% | -14.42% | 34.27% |
| EPS Diluted | 92.03% | 1,618.03% | -18.73% | 62.11% | -46.30% |
| Normalized Diluted EPS | 11.98% | 45.85% | 74.77% | -14.74% | 33.77% |
| Average Basic Shares Outstanding | 0.19% | 0.37% | 0.37% | 0.37% | 0.37% |
| Average Diluted Shares Outstanding | 0.00% | 0.93% | 0.37% | 0.74% | 0.74% |
| Dividend Per Share | 5.78% | 5.78% | 5.63% | 5.63% | 5.63% |
| Payout Ratio | -0.45% | 1.07% | 0.29% | -0.35% | 0.96% |